Julius Knowles serves as Executive at Keros Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Julius Knowles has executed 265 insider transactions totaling $28.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 1, 2021 involved selling 516 shares valued at $34.1K.
Julius Knowles currently holds 102,233 shares of Keros Therapeutics, Inc. (KROS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julius Knowles has been a net seller of KROS stock. They have purchased $25.0K and sold $28.8M worth of shares.
Julius Knowles's most recent insider trade was on Mar 1, 2021, when they sold 516 shares at $66.04 per share.
Get notified when new Form 4 filings are submitted
| $66.04 |
| Discretionary |
| Mar 1, 2021 | KROS | $31.3K | Sale | 479 | $65.28 | Discretionary |
| Mar 1, 2021 | KROS | $47.9K | Sale | 734 | $65.29 | Discretionary |
| Mar 1, 2021 | KROS | $26.0K | Sale | 406 | $64.09 | Discretionary |
| Mar 1, 2021 | KROS | $40.1K | Sale | 625 | $64.09 | Discretionary |
| Mar 1, 2021 | KROS | $73.9K | Sale | 1,169 | $63.22 | Discretionary |
| Mar 1, 2021 | KROS | $113.4K | Sale | 1,794 | $63.22 | Discretionary |
| Feb 18, 2021 | KROS | $4.9K | Sale | 75 | $65.01 | Discretionary |
| Feb 18, 2021 | KROS | $7.5K | Sale | 116 | $65.02 | Discretionary |
| Feb 18, 2021 | KROS | $35.4K | Sale | 552 | $64.17 | Discretionary |
| Feb 18, 2021 | KROS | $54.2K | Sale | 845 | $64.16 | Discretionary |
| Feb 18, 2021 | KROS | $12.9K | Sale | 205 | $63.04 | Discretionary |
| Feb 18, 2021 | KROS | $19.9K | Sale | 315 | $63.04 | Discretionary |
| Feb 18, 2021 | KROS | $11.1K | Sale | 180 | $61.68 | Discretionary |
| Feb 18, 2021 | KROS | $17.0K | Sale | 276 | $61.68 | Discretionary |
| Feb 18, 2021 | KROS | $9.0K | Sale | 150 | $60.06 | Discretionary |
| Feb 18, 2021 | KROS | $13.8K | Sale | 230 | $60.06 | Discretionary |
| Feb 17, 2021 | KROS | $106.9K | Sale | 1,705 | $62.72 | Discretionary |
| Feb 17, 2021 | KROS | $74.2K | Sale | 1,201 | $61.80 | Discretionary |
| Feb 17, 2021 | KROS | $113.8K | Sale | 1,841 | $61.80 | Discretionary |
| Feb 17, 2021 | KROS | $46.3K | Sale | 764 | $60.66 | Discretionary |
| Feb 17, 2021 | KROS | $163.9K | Sale | 2,613 | $62.72 | Discretionary |
| Feb 17, 2021 | KROS | $71.2K | Sale | 1,173 | $60.66 | Discretionary |
| Feb 17, 2021 | KROS | $134.9K | Sale | 2,249 | $59.96 | Discretionary |
| Feb 17, 2021 | KROS | $206.8K | Sale | 3,449 | $59.96 | Discretionary |
| Feb 17, 2021 | KROS | $24.7K | Sale | 421 | $58.74 | Discretionary |
| Feb 17, 2021 | KROS | $37.9K | Sale | 645 | $58.74 | Discretionary |
| Feb 16, 2021 | KROS | $60.2K | Sale | 1,014 | $59.34 | Discretionary |
| Feb 16, 2021 | KROS | $25.4K | Sale | 434 | $58.48 | Discretionary |